NL-OMON29407已完成不适用
Three arm randomized parallel phase II/III study evaluating the efficacy and safety of the combinations Epirubicin and Taxotere (ET), Taxotere and Navelbine (TN) and Navelbine and Epirubicin (EN) as first line therapy in patients with metastatic breast cancer.
VU medical center.0 个研究点目标入组 111 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 111
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Histologically proven breast cancer at first diagnosis. At study entry histological or cytological proof of metastasis is required in case of a single metastatic target lesion.
- •Female metastatic breast cancer patients
- •Measurable disease or evaluable disease (bone metastases only allowed).
排除标准
- •1. Prior chemotherapy for metastatic disease.
- •2. Locally advanced inoperable breast cancer (Stage III B) as only manifestation of the disease.
研究者
相似试验
Unknown
3 期
A Phase III Study in Subjects With Mild to Moderate Psoriasis.Mild to Moderate PsoriasisNCT05249972Lipidor AB294
已完成
3 期
Efficacy of Fixed Combination of Beclometasone + Formoterol + Glycopyrrolate Versus Foster® in COPDNCT01917331Chiesi Farmaceutici S.p.A.1,368
进行中（未招募）
3 期
RCT, Blinded, 2-Arm Efficacy Study of IP and Placebo in Patients With Chronic Pain Related to Osteoarthritis of the KneeDegenerative ArthritisNCT05318521Overseas Pharmaceuticals, Ltd.500
撤回
3 期
Evaluate the Efficacy and Safety of HLX01 Versus Mabthera in Patients With Low Tumour Burden Follicular Lymphoma.CD20-positive Follicular Lymphoma, With Low Tumour BurdenNCT04671420Shanghai Henlius Biotech
进行中（未招募）
3 期
Study to Evaluate the Efficacy and Safety of Venglustat in Adult and Pediatric Patients With Gaucher Disease Type 3Gaucher's Disease Type IIINCT05222906Sanofi43